Variable | Severe Asthmatics (n = 77) | Moderate Asthmatics (n = 48) | p-value |
---|---|---|---|
Sputum Neutrophils (%) | 49.0 (31.2) | 43.1 (26.3) | 0.32 |
Sputum Eosinophils (%) | 11.8 (17.6) | 4.6 (6.5) | 0.01 |
Age | 49.9 (12.6) | 46.6 (11.2) | 0.13 |
BMI | 28.1 (5.8) | 27.7 (6.9) | 0.74 |
Age-of-Onset (AOO) | 22.9 (18.0) | 22.1 (14.7) | 0.77 |
Beclamethasone or equivalent dose (mcg) | 1340.7 (524.1) | 677.2 (425.5) | <0.01 |
FENO (ppb) | 30.5 (28.6) | 20.4 (18.2) | 0.02 |
ACQ | 2.0 (1.0) | 1.0 (0.8) | <0.01 |
FEV1(%) | 63.4 (19.7) | 87.2 (12.5) | <0.01 |
FEV1/FVC | 64.9 (12.2) | 74.1 (8.5) | <0.01 |
Prednisone user [n (%)] | 41 (53 %) | 2 (4 %) | <0.01 |
Omalizumab user [n (%)] | 8 (10 %) | 0 (0 %) | 0.02 |
Males [n (%)] | 43 (56 %) | 23 (48 %) | 0.50 |
Non Smoker [n (%)] | 52 (67.5 %) | 25 (53 %) | 0.16 |
Atopic [n (%)] | 58 (81 %) | 42 (87.5 %) | 0.45 |